Newsletter registration

Используя наш сайт, Вы соглашаетесь с тем, что в целях обеспечения оптимального сервиса на Вашем компьютере будут сохраняться файлы Cookie и будет использоваться служба Google Analytics. Более подробную информацию об этом Вы найдетездесь.
Австрия
Динамичная площадка для ведения бизнеса

Swallowable cancer immune therapy being developed

Apeiron Biologics CEO Hans Loibner said: "Our concept is that we would like to develop small molecule (synthetically produced) substances which provide the immune system with specific properties.” Apeiron and Evotec established a screening system to search through a substance library containing about 100,000 substances to find an enhancing effect on immune cells. Several drug candidates were discovered within the context of the project APN411.

In contrast to monoclonal antibodies, the new drug candidates showed in laboratory tests that they could trigger several effects in the immune cells. These produce more of the anti-tumor messenger substances interleukin-2, interferon gamma and tumor necrosis factor alpha. The T-cells showed enhanced activity.  

It is also decisive for the project that the substances are small and can be very effectively produced on an industrial scale.  

Apeiron, founded by Josef Penninger, Head of the Institute for Molecular Biotechnology in Vienna (IMBA), is already involved in early clinical tests in the USA with APN401, another cancer checkpoint project. A medicine developed by Apeiron to treat brain tumors in children is awaiting approval by the European Medicines Agency (EMA). 

Share on Facebook Share on Facebook Share on Twitter Share on Twitter

Отзывы

Мероприятия

Познакомьтесь с нами в рамках мероприятий, семинаров и выставок по всему миру

Austria Map

Find the perfect location for your company

Выбор столицы Австрии в качестве места учреждения первого зарубежного офиса Национального Рейтингового Агентства абсолютно не случаен. У Австрии и России давнишняя история дружественных и взаимовыгодных отношений. И сейчас Австрия для России остается одним из самых комфортных и дружелюбных партнеров в ЕС.

Национальное Рейтинговое Агентство

Logo Национальное Рейтинговое Агентство
Все отзывы

Новости Австрии, как площадки для бизнеса

September 12-14, 2018: 1MillionStartups Global Conference in Vienna

The Viennese startup hub weXelerate is hosting the very first 1MillionStartups Global Conference from September 12-14, 2018.

Testing the potential early detection of ovarian cancer

About 75 percent of the cases of extremely aggressive ovarian cancer (ovarian carcinoma) originally arise in the fallopian tube. Currently there are no possibilities to detect this at an early stage. A new catheter system developed by Viennese scientists could represent a new possibility to deal with this.

Все новости